Global Gefitinib Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Gefitinib Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Gefitinib by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Gefitinib by Country/Region, 2017, 2022 & 2028

2.2 Gefitinib Segment by Type

2.2.1 10 Tables/Box

2.2.2 30 Tables/Box

2.2.3 90 Tables/Box

2.3 Gefitinib Sales by Type

2.3.1 Global Gefitinib Sales Market Share by Type (2017-2022)

2.3.2 Global Gefitinib Revenue and Market Share by Type (2017-2022)

2.3.3 Global Gefitinib Sale Price by Type (2017-2022)

2.4 Gefitinib Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Drug Center

2.4.4 Other

2.5 Gefitinib Sales by Application

2.5.1 Global Gefitinib Sale Market Share by Application (2017-2022)

2.5.2 Global Gefitinib Revenue and Market Share by Application (2017-2022)

2.5.3 Global Gefitinib Sale Price by Application (2017-2022)

3 Global Gefitinib by Company

3.1 Global Gefitinib Breakdown Data by Company

3.1.1 Global Gefitinib Annual Sales by Company (2020-2022)

3.1.2 Global Gefitinib Sales Market Share by Company (2020-2022)

3.2 Global Gefitinib Annual Revenue by Company (2020-2022)

3.2.1 Global Gefitinib Revenue by Company (2020-2022)

3.2.2 Global Gefitinib Revenue Market Share by Company (2020-2022)

3.3 Global Gefitinib Sale Price by Company

3.4 Key Manufacturers Gefitinib Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Gefitinib Product Location Distribution

3.4.2 Players Gefitinib Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Gefitinib by Geographic Region

4.1 World Historic Gefitinib Market Size by Geographic Region (2017-2022)

4.1.1 Global Gefitinib Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Gefitinib Annual Revenue by Geographic Region

4.2 World Historic Gefitinib Market Size by Country/Region (2017-2022)

4.2.1 Global Gefitinib Annual Sales by Country/Region (2017-2022)

4.2.2 Global Gefitinib Annual Revenue by Country/Region

4.3 Americas Gefitinib Sales Growth

4.4 APAC Gefitinib Sales Growth

4.5 Europe Gefitinib Sales Growth

4.6 Middle East & Africa Gefitinib Sales Growth

5 Americas

5.1 Americas Gefitinib Sales by Country

5.1.1 Americas Gefitinib Sales by Country (2017-2022)

5.1.2 Americas Gefitinib Revenue by Country (2017-2022)

5.2 Americas Gefitinib Sales by Type

5.3 Americas Gefitinib Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Gefitinib Sales by Region

6.1.1 APAC Gefitinib Sales by Region (2017-2022)

6.1.2 APAC Gefitinib Revenue by Region (2017-2022)

6.2 APAC Gefitinib Sales by Type

6.3 APAC Gefitinib Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Gefitinib by Country

7.1.1 Europe Gefitinib Sales by Country (2017-2022)

7.1.2 Europe Gefitinib Revenue by Country (2017-2022)

7.2 Europe Gefitinib Sales by Type

7.3 Europe Gefitinib Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Gefitinib by Country

8.1.1 Middle East & Africa Gefitinib Sales by Country (2017-2022)

8.1.2 Middle East & Africa Gefitinib Revenue by Country (2017-2022)

8.2 Middle East & Africa Gefitinib Sales by Type

8.3 Middle East & Africa Gefitinib Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Gefitinib

10.3 Manufacturing Process Analysis of Gefitinib

10.4 Industry Chain Structure of Gefitinib

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Gefitinib Distributors

11.3 Gefitinib Customer

12 World Forecast Review for Gefitinib by Geographic Region

12.1 Global Gefitinib Market Size Forecast by Region

12.1.1 Global Gefitinib Forecast by Region (2023-2028)

12.1.2 Global Gefitinib Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Gefitinib Forecast by Type

12.7 Global Gefitinib Forecast by Application

13 Key Players Analysis

13.1 AstraZeneca

13.1.1 AstraZeneca Company Information

13.1.2 AstraZeneca Gefitinib Product Offered

13.1.3 AstraZeneca Gefitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AstraZeneca Main Business Overview

13.1.5 AstraZeneca Latest Developments

13.2 Qilu Pharmaceutical

13.2.1 Qilu Pharmaceutical Company Information

13.2.2 Qilu Pharmaceutical Gefitinib Product Offered

13.2.3 Qilu Pharmaceutical Gefitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Qilu Pharmaceutical Main Business Overview

13.2.5 Qilu Pharmaceutical Latest Developments

13.3 Natco Pharma

13.3.1 Natco Pharma Company Information

13.3.2 Natco Pharma Gefitinib Product Offered

13.3.3 Natco Pharma Gefitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Natco Pharma Main Business Overview

13.3.5 Natco Pharma Latest Developments

13.4 Celon Laboratories

13.4.1 Celon Laboratories Company Information

13.4.2 Celon Laboratories Gefitinib Product Offered

13.4.3 Celon Laboratories Gefitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Celon Laboratories Main Business Overview

13.4.5 Celon Laboratories Latest Developments

13.5 Hetero Drugs

13.5.1 Hetero Drugs Company Information

13.5.2 Hetero Drugs Gefitinib Product Offered

13.5.3 Hetero Drugs Gefitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Hetero Drugs Main Business Overview

13.5.5 Hetero Drugs Latest Developments

13.6 Dr Reddy's Laboratories

13.6.1 Dr Reddy's Laboratories Company Information

13.6.2 Dr Reddy's Laboratories Gefitinib Product Offered

13.6.3 Dr Reddy's Laboratories Gefitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Dr Reddy's Laboratories Main Business Overview

13.6.5 Dr Reddy's Laboratories Latest Developments

13.7 Zuventus Healthcare

13.7.1 Zuventus Healthcare Company Information

13.7.2 Zuventus Healthcare Gefitinib Product Offered

13.7.3 Zuventus Healthcare Gefitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Zuventus Healthcare Main Business Overview

13.7.5 Zuventus Healthcare Latest Developments

13.8 United Biotech

13.8.1 United Biotech Company Information

13.8.2 United Biotech Gefitinib Product Offered

13.8.3 United Biotech Gefitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 United Biotech Main Business Overview

13.8.5 United Biotech Latest Developments

13.9 Panacea Biotec

13.9.1 Panacea Biotec Company Information

13.9.2 Panacea Biotec Gefitinib Product Offered

13.9.3 Panacea Biotec Gefitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Panacea Biotec Main Business Overview

13.9.5 Panacea Biotec Latest Developments

13.10 Cipla

13.10.1 Cipla Company Information

13.10.2 Cipla Gefitinib Product Offered

13.10.3 Cipla Gefitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Cipla Main Business Overview

13.10.5 Cipla Latest Developments

13.11 Glenmark Pharmaceuticals

13.11.1 Glenmark Pharmaceuticals Company Information

13.11.2 Glenmark Pharmaceuticals Gefitinib Product Offered

13.11.3 Glenmark Pharmaceuticals Gefitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Glenmark Pharmaceuticals Main Business Overview

13.11.5 Glenmark Pharmaceuticals Latest Developments

13.12 Nobel Ilac Sanayii Ve Ticaret

13.12.1 Nobel Ilac Sanayii Ve Ticaret Company Information

13.12.2 Nobel Ilac Sanayii Ve Ticaret Gefitinib Product Offered

13.12.3 Nobel Ilac Sanayii Ve Ticaret Gefitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Nobel Ilac Sanayii Ve Ticaret Main Business Overview

13.12.5 Nobel Ilac Sanayii Ve Ticaret Latest Developments

13.13 Accure Labs

13.13.1 Accure Labs Company Information

13.13.2 Accure Labs Gefitinib Product Offered

13.13.3 Accure Labs Gefitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Accure Labs Main Business Overview

13.13.5 Accure Labs Latest Developments

13.14 Cadila Pharmaceuticals

13.14.1 Cadila Pharmaceuticals Company Information

13.14.2 Cadila Pharmaceuticals Gefitinib Product Offered

13.14.3 Cadila Pharmaceuticals Gefitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Cadila Pharmaceuticals Main Business Overview

13.14.5 Cadila Pharmaceuticals Latest Developments

13.15 Ethypharm

13.15.1 Ethypharm Company Information

13.15.2 Ethypharm Gefitinib Product Offered

13.15.3 Ethypharm Gefitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Ethypharm Main Business Overview

13.15.5 Ethypharm Latest Developments

13.16 Flagship Biotech International

13.16.1 Flagship Biotech International Company Information

13.16.2 Flagship Biotech International Gefitinib Product Offered

13.16.3 Flagship Biotech International Gefitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Flagship Biotech International Main Business Overview

13.16.5 Flagship Biotech International Latest Developments

13.17 Globela Pharma

13.17.1 Globela Pharma Company Information

13.17.2 Globela Pharma Gefitinib Product Offered

13.17.3 Globela Pharma Gefitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Globela Pharma Main Business Overview

13.17.5 Globela Pharma Latest Developments

13.18 Jodas Expoim

13.18.1 Jodas Expoim Company Information

13.18.2 Jodas Expoim Gefitinib Product Offered

13.18.3 Jodas Expoim Gefitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Jodas Expoim Main Business Overview

13.18.5 Jodas Expoim Latest Developments

13.19 Nishchay Pharmaceuticals

13.19.1 Nishchay Pharmaceuticals Company Information

13.19.2 Nishchay Pharmaceuticals Gefitinib Product Offered

13.19.3 Nishchay Pharmaceuticals Gefitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Nishchay Pharmaceuticals Main Business Overview

13.19.5 Nishchay Pharmaceuticals Latest Developments

13.20 Sichuan Xieli Pharmaceutical

13.20.1 Sichuan Xieli Pharmaceutical Company Information

13.20.2 Sichuan Xieli Pharmaceutical Gefitinib Product Offered

13.20.3 Sichuan Xieli Pharmaceutical Gefitinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Sichuan Xieli Pharmaceutical Main Business Overview

13.20.5 Sichuan Xieli Pharmaceutical Latest Developments

14 Research Findings and Conclusion

Table 1. Gefitinib Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Gefitinib Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 10 Tables/Box

Table 4. Major Players of 30 Tables/Box

Table 5. Major Players of 90 Tables/Box

Table 6. Global Gefitinib Sales by Type (2017-2022) & (K Pcs)

Table 7. Global Gefitinib Sales Market Share by Type (2017-2022)

Table 8. Global Gefitinib Revenue by Type (2017-2022) & ($ million)

Table 9. Global Gefitinib Revenue Market Share by Type (2017-2022)

Table 10. Global Gefitinib Sale Price by Type (2017-2022) & (USD/Pcs)

Table 11. Global Gefitinib Sales by Application (2017-2022) & (K Pcs)

Table 12. Global Gefitinib Sales Market Share by Application (2017-2022)

Table 13. Global Gefitinib Revenue by Application (2017-2022)

Table 14. Global Gefitinib Revenue Market Share by Application (2017-2022)

Table 15. Global Gefitinib Sale Price by Application (2017-2022) & (USD/Pcs)

Table 16. Global Gefitinib Sales by Company (2020-2022) & (K Pcs)

Table 17. Global Gefitinib Sales Market Share by Company (2020-2022)

Table 18. Global Gefitinib Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Gefitinib Revenue Market Share by Company (2020-2022)

Table 20. Global Gefitinib Sale Price by Company (2020-2022) & (USD/Pcs)

Table 21. Key Manufacturers Gefitinib Producing Area Distribution and Sales Area

Table 22. Players Gefitinib Products Offered

Table 23. Gefitinib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Gefitinib Sales by Geographic Region (2017-2022) & (K Pcs)

Table 27. Global Gefitinib Sales Market Share Geographic Region (2017-2022)

Table 28. Global Gefitinib Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Gefitinib Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Gefitinib Sales by Country/Region (2017-2022) & (K Pcs)

Table 31. Global Gefitinib Sales Market Share by Country/Region (2017-2022)

Table 32. Global Gefitinib Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Gefitinib Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Gefitinib Sales by Country (2017-2022) & (K Pcs)

Table 35. Americas Gefitinib Sales Market Share by Country (2017-2022)

Table 36. Americas Gefitinib Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Gefitinib Revenue Market Share by Country (2017-2022)

Table 38. Americas Gefitinib Sales by Type (2017-2022) & (K Pcs)

Table 39. Americas Gefitinib Sales Market Share by Type (2017-2022)

Table 40. Americas Gefitinib Sales by Application (2017-2022) & (K Pcs)

Table 41. Americas Gefitinib Sales Market Share by Application (2017-2022)

Table 42. APAC Gefitinib Sales by Region (2017-2022) & (K Pcs)

Table 43. APAC Gefitinib Sales Market Share by Region (2017-2022)

Table 44. APAC Gefitinib Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Gefitinib Revenue Market Share by Region (2017-2022)

Table 46. APAC Gefitinib Sales by Type (2017-2022) & (K Pcs)

Table 47. APAC Gefitinib Sales Market Share by Type (2017-2022)

Table 48. APAC Gefitinib Sales by Application (2017-2022) & (K Pcs)

Table 49. APAC Gefitinib Sales Market Share by Application (2017-2022)

Table 50. Europe Gefitinib Sales by Country (2017-2022) & (K Pcs)

Table 51. Europe Gefitinib Sales Market Share by Country (2017-2022)

Table 52. Europe Gefitinib Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Gefitinib Revenue Market Share by Country (2017-2022)

Table 54. Europe Gefitinib Sales by Type (2017-2022) & (K Pcs)

Table 55. Europe Gefitinib Sales Market Share by Type (2017-2022)

Table 56. Europe Gefitinib Sales by Application (2017-2022) & (K Pcs)

Table 57. Europe Gefitinib Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Gefitinib Sales by Country (2017-2022) & (K Pcs)

Table 59. Middle East & Africa Gefitinib Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Gefitinib Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Gefitinib Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Gefitinib Sales by Type (2017-2022) & (K Pcs)

Table 63. Middle East & Africa Gefitinib Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Gefitinib Sales by Application (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Gefitinib Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Gefitinib

Table 67. Key Market Challenges & Risks of Gefitinib

Table 68. Key Industry Trends of Gefitinib

Table 69. Gefitinib Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Gefitinib Distributors List

Table 72. Gefitinib Customer List

Table 73. Global Gefitinib Sales Forecast by Region (2023-2028) & (K Pcs)

Table 74. Global Gefitinib Sales Market Forecast by Region

Table 75. Global Gefitinib Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Gefitinib Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Gefitinib Sales Forecast by Country (2023-2028) & (K Pcs)

Table 78. Americas Gefitinib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Gefitinib Sales Forecast by Region (2023-2028) & (K Pcs)

Table 80. APAC Gefitinib Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Gefitinib Sales Forecast by Country (2023-2028) & (K Pcs)

Table 82. Europe Gefitinib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Gefitinib Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Middle East & Africa Gefitinib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Gefitinib Sales Forecast by Type (2023-2028) & (K Pcs)

Table 86. Global Gefitinib Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Gefitinib Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Gefitinib Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Gefitinib Sales Forecast by Application (2023-2028) & (K Pcs)

Table 90. Global Gefitinib Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Gefitinib Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Gefitinib Revenue Market Share Forecast by Application (2023-2028)

Table 93. AstraZeneca Basic Information, Gefitinib Manufacturing Base, Sales Area and Its Competitors

Table 94. AstraZeneca Gefitinib Product Offered

Table 95. AstraZeneca Gefitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 96. AstraZeneca Main Business

Table 97. AstraZeneca Latest Developments

Table 98. Qilu Pharmaceutical Basic Information, Gefitinib Manufacturing Base, Sales Area and Its Competitors

Table 99. Qilu Pharmaceutical Gefitinib Product Offered

Table 100. Qilu Pharmaceutical Gefitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 101. Qilu Pharmaceutical Main Business

Table 102. Qilu Pharmaceutical Latest Developments

Table 103. Natco Pharma Basic Information, Gefitinib Manufacturing Base, Sales Area and Its Competitors

Table 104. Natco Pharma Gefitinib Product Offered

Table 105. Natco Pharma Gefitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 106. Natco Pharma Main Business

Table 107. Natco Pharma Latest Developments

Table 108. Celon Laboratories Basic Information, Gefitinib Manufacturing Base, Sales Area and Its Competitors

Table 109. Celon Laboratories Gefitinib Product Offered

Table 110. Celon Laboratories Gefitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 111. Celon Laboratories Main Business

Table 112. Celon Laboratories Latest Developments

Table 113. Hetero Drugs Basic Information, Gefitinib Manufacturing Base, Sales Area and Its Competitors

Table 114. Hetero Drugs Gefitinib Product Offered

Table 115. Hetero Drugs Gefitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 116. Hetero Drugs Main Business

Table 117. Hetero Drugs Latest Developments

Table 118. Dr Reddy's Laboratories Basic Information, Gefitinib Manufacturing Base, Sales Area and Its Competitors

Table 119. Dr Reddy's Laboratories Gefitinib Product Offered

Table 120. Dr Reddy's Laboratories Gefitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 121. Dr Reddy's Laboratories Main Business

Table 122. Dr Reddy's Laboratories Latest Developments

Table 123. Zuventus Healthcare Basic Information, Gefitinib Manufacturing Base, Sales Area and Its Competitors

Table 124. Zuventus Healthcare Gefitinib Product Offered

Table 125. Zuventus Healthcare Gefitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 126. Zuventus Healthcare Main Business

Table 127. Zuventus Healthcare Latest Developments

Table 128. United Biotech Basic Information, Gefitinib Manufacturing Base, Sales Area and Its Competitors

Table 129. United Biotech Gefitinib Product Offered

Table 130. United Biotech Gefitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 131. United Biotech Main Business

Table 132. United Biotech Latest Developments

Table 133. Panacea Biotec Basic Information, Gefitinib Manufacturing Base, Sales Area and Its Competitors

Table 134. Panacea Biotec Gefitinib Product Offered

Table 135. Panacea Biotec Gefitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 136. Panacea Biotec Main Business

Table 137. Panacea Biotec Latest Developments

Table 138. Cipla Basic Information, Gefitinib Manufacturing Base, Sales Area and Its Competitors

Table 139. Cipla Gefitinib Product Offered

Table 140. Cipla Gefitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 141. Cipla Main Business

Table 142. Cipla Latest Developments

Table 143. Glenmark Pharmaceuticals Basic Information, Gefitinib Manufacturing Base, Sales Area and Its Competitors

Table 144. Glenmark Pharmaceuticals Gefitinib Product Offered

Table 145. Glenmark Pharmaceuticals Gefitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 146. Glenmark Pharmaceuticals Main Business

Table 147. Glenmark Pharmaceuticals Latest Developments

Table 148. Nobel Ilac Sanayii Ve Ticaret Basic Information, Gefitinib Manufacturing Base, Sales Area and Its Competitors

Table 149. Nobel Ilac Sanayii Ve Ticaret Gefitinib Product Offered

Table 150. Nobel Ilac Sanayii Ve Ticaret Gefitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 151. Nobel Ilac Sanayii Ve Ticaret Main Business

Table 152. Nobel Ilac Sanayii Ve Ticaret Latest Developments

Table 153. Accure Labs Basic Information, Gefitinib Manufacturing Base, Sales Area and Its Competitors

Table 154. Accure Labs Gefitinib Product Offered

Table 155. Accure Labs Gefitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 156. Accure Labs Main Business

Table 157. Accure Labs Latest Developments

Table 158. Cadila Pharmaceuticals Basic Information, Gefitinib Manufacturing Base, Sales Area and Its Competitors

Table 159. Cadila Pharmaceuticals Gefitinib Product Offered

Table 160. Cadila Pharmaceuticals Gefitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 161. Cadila Pharmaceuticals Main Business

Table 162. Cadila Pharmaceuticals Latest Developments

Table 163. Ethypharm Basic Information, Gefitinib Manufacturing Base, Sales Area and Its Competitors

Table 164. Ethypharm Gefitinib Product Offered

Table 165. Ethypharm Gefitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 166. Ethypharm Main Business

Table 167. Ethypharm Latest Developments

Table 168. Flagship Biotech International Basic Information, Gefitinib Manufacturing Base, Sales Area and Its Competitors

Table 169. Flagship Biotech International Gefitinib Product Offered

Table 170. Flagship Biotech International Gefitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 171. Flagship Biotech International Main Business

Table 172. Flagship Biotech International Latest Developments

Table 173. Globela Pharma Basic Information, Gefitinib Manufacturing Base, Sales Area and Its Competitors

Table 174. Globela Pharma Gefitinib Product Offered

Table 175. Globela Pharma Gefitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 176. Globela Pharma Main Business

Table 177. Globela Pharma Latest Developments

Table 178. Jodas Expoim Basic Information, Gefitinib Manufacturing Base, Sales Area and Its Competitors

Table 179. Jodas Expoim Gefitinib Product Offered

Table 180. Jodas Expoim Gefitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 181. Jodas Expoim Main Business

Table 182. Jodas Expoim Latest Developments

Table 183. Nishchay Pharmaceuticals Basic Information, Gefitinib Manufacturing Base, Sales Area and Its Competitors

Table 184. Nishchay Pharmaceuticals Gefitinib Product Offered

Table 185. Nishchay Pharmaceuticals Gefitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 186. Nishchay Pharmaceuticals Main Business

Table 187. Nishchay Pharmaceuticals Latest Developments

Table 188. Sichuan Xieli Pharmaceutical Basic Information, Gefitinib Manufacturing Base, Sales Area and Its Competitors

Table 189. Sichuan Xieli Pharmaceutical Gefitinib Product Offered

Table 190. Sichuan Xieli Pharmaceutical Gefitinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 191. Sichuan Xieli Pharmaceutical Main Business

Table 192. Sichuan Xieli Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Gefitinib

Figure 2. Gefitinib Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Gefitinib Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Gefitinib Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Gefitinib Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 10 Tables/Box

Figure 10. Product Picture of 30 Tables/Box

Figure 11. Product Picture of 90 Tables/Box

Figure 12. Global Gefitinib Sales Market Share by Type in 2021

Figure 13. Global Gefitinib Revenue Market Share by Type (2017-2022)

Figure 14. Gefitinib Consumed in Hospital

Figure 15. Global Gefitinib Market: Hospital (2017-2022) & (K Pcs)

Figure 16. Gefitinib Consumed in Clinic

Figure 17. Global Gefitinib Market: Clinic (2017-2022) & (K Pcs)

Figure 18. Gefitinib Consumed in Drug Center

Figure 19. Global Gefitinib Market: Drug Center (2017-2022) & (K Pcs)

Figure 20. Gefitinib Consumed in Other

Figure 21. Global Gefitinib Market: Other (2017-2022) & (K Pcs)

Figure 22. Global Gefitinib Sales Market Share by Application (2017-2022)

Figure 23. Global Gefitinib Revenue Market Share by Application in 2021

Figure 24. Gefitinib Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Gefitinib Revenue Market Share by Company in 2021

Figure 26. Global Gefitinib Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Gefitinib Revenue Market Share by Geographic Region in 2021

Figure 28. Global Gefitinib Sales Market Share by Region (2017-2022)

Figure 29. Global Gefitinib Revenue Market Share by Country/Region in 2021

Figure 30. Americas Gefitinib Sales 2017-2022 (K Pcs)

Figure 31. Americas Gefitinib Revenue 2017-2022 ($ Millions)

Figure 32. APAC Gefitinib Sales 2017-2022 (K Pcs)

Figure 33. APAC Gefitinib Revenue 2017-2022 ($ Millions)

Figure 34. Europe Gefitinib Sales 2017-2022 (K Pcs)

Figure 35. Europe Gefitinib Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Gefitinib Sales 2017-2022 (K Pcs)

Figure 37. Middle East & Africa Gefitinib Revenue 2017-2022 ($ Millions)

Figure 38. Americas Gefitinib Sales Market Share by Country in 2021

Figure 39. Americas Gefitinib Revenue Market Share by Country in 2021

Figure 40. United States Gefitinib Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Gefitinib Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Gefitinib Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Gefitinib Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Gefitinib Sales Market Share by Region in 2021

Figure 45. APAC Gefitinib Revenue Market Share by Regions in 2021

Figure 46. China Gefitinib Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Gefitinib Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Gefitinib Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Gefitinib Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Gefitinib Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Gefitinib Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Gefitinib Sales Market Share by Country in 2021

Figure 53. Europe Gefitinib Revenue Market Share by Country in 2021

Figure 54. Germany Gefitinib Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Gefitinib Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Gefitinib Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Gefitinib Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Gefitinib Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Gefitinib Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Gefitinib Revenue Market Share by Country in 2021

Figure 61. Egypt Gefitinib Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Gefitinib Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Gefitinib Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Gefitinib Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Gefitinib Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Gefitinib in 2021

Figure 67. Manufacturing Process Analysis of Gefitinib

Figure 68. Industry Chain Structure of Gefitinib

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles